Erratum: Oxidative stress in normal-weight obese syndrome (Obesity 18 (2125-2130) DOI: 10.1038/oby.2010.50);Oxidative stress in normal-weight obese syndrome

Obesity

Volumn 18, Issue 11, 2010, Pages 2125-2130

  Di Renzo, Laura ^a,b   Galvano, Fabio ^c   Orlandi, Carmine ^a   Bianchi, Alessia ^a   Di Giacomo, Claudia ^c   La Fauci, Luca ^c   Acquaviva, Rosaria ^c   De Lorenzo, Antonino ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INDiM   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049260011     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.93     Document Type: Erratum

References (39)

1. Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids 2005;73:9-15.
2. Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab 2005;16:307-313.
3. Coppak SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-356.
4. De Lorenzo A, Deurenberg P, Pietrantuono M et al. How fat is obese? Acta Diabetol 2003;40 Suppl 1:S254-S257.
5. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman E T. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
6. Deurenberg P, Deurenberg-Yap M, Schouten FJ. Validity of total and segmental impedance measurements for prediction of body composition across ethnic population groups. Eur J Clin Nutr 2002;56:214-220.
7. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
8. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.
9. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 2006;16:513-523.
10. De Lorenzo A, Del Gobbo V, Premrov MG et al. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 2007;85:40-45.
11. Di Renzo L, Del Gobbo V, Bigioni M et al. Body composition analyses in normal weight obese women. Eur Rev Med Pharmacol Sci 2006;10:191-196.
12. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008;19:491-504.
13. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008;54:945-955.
14. Diet, nutrition and the prevention of chronic diseases. Word Health Organ Tech Rep Ser 2003;916:1-149.
15. Parodi E, De Lorenzo A. Diet, nutrition and prevention of chronic diseases. Geneva: WHO Technical Report Series; 2003. no. 916. www.enpam.it.
16. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1998.
17. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol 1994;233:380-385.
18. Wolff S. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 1994;233:183-189.
19. Ricart-Jané D, Llobera M, López-Tejero MD. Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide 2002;6:178-185.
20. Russo A, Acquaviva R, Campisi A et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol Toxicol 2000; 16:91-98.
21. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
22. Keaney JF Jr, Larson MG, Vasan RS et al.; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434-439.
23. Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007;29:98-114.
24. Park J, Chung JJ, Kim JB. New evaluations of redox regulating system in adipose tissue of obesity. Diabetes Res Clin Pract 2007;77 Suppl 1:S11-S16.
25. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002;26:1159-1164.
26. Brown LA, Kerr CJ, Whiting P et al. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity 2009;17:460-466.
27. Galinier A, Carrière A, Fernandez Y et al. Adipose tissue proadipogenic redox changes in obesity. J Biol Chem 2006;281:12682-12687.
28. Faber P, Johnstone AM, Gibney ER et al. The effect of rate of weight loss on erythrocyte glutathione concentration and synthesis in healthy obese men. Clin Sci 2002;102:569-577.
29. Mutlu-Türkoglu U, Oztezcan S, Telci A et al. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2003;2:171-174.
30. Davì G, Guagnano MT, Ciabattoni G et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288:2008-2014.
31. Marques-Vidal P, Pécoud A, Hayoz D et al. Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr 2008; 47:251-257.
32. Shankar SS, Steinberg HO. Obesity and endothelial dysfunction. Semin Vasc Med 2005;5:56-64.
33. Konukoglu D, Serin O, Turhan MS. Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels. Clin Hemorheol Microcirc 2005;33:41-46.
34. Di Renzo L, Gloria-Bottini F, Saccucci P et al. Role of interleukin-15 receptor α polymorphisms in normal weight obese syndrome. Int J Immunopathol Pharmacol 2009;22:105-113.
35. Di Renzo L, Bertoli A, Bigioni M et al. Body composition and-174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des 2008;14:2699-2706.
36. Di Renzo L, Bigioni M, Del Gobbo V et al. Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1α and β plasma levels. Pharmacol Res 2007;55:131-138.
37. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006;30:400-418.
38. Karalis K P, Giannogonas P, Kodela E et al. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009;276:5747-5754.
39. De Lorenzo A, Di Renzo L, Puja A et al. A study of acid phosphatase locus 1 in women with high fat content and normal body mass index. Metab Clin Exp 2009;58:351-354.